| abstract |
the present invention relates to new solid forms of compound (i), acetate of [(1s) -1 - [(2s, 4r, 5r) -5- (5-amino-2-oxo-thiazole [4,5 -d] pyrimidin-3-yl) -4-hydroxy-tetrahydrofuran-2-yl] propyl] and pharmaceutical compositions comprising their solid forms set out in the present case, which can be used as a tlr7 agonist, or for the treatment or prophylaxis of a viral illness in a patient related to hbv infection or a disease caused by hbv infection. |